About
Bringing clinical-grade bone health screening to every clinic
Osteofy is a health technology company building AI-powered bone mineral density analysis — making osteoporosis screening faster, more accessible, and more consistent.
Closing the gap in osteoporosis detection
Osteoporosis affects over 200 million people worldwide, yet the majority remain undiagnosed until a fracture occurs. The gold standard for bone density screening — DXA — is expensive, underused, and out of reach for many patients and healthcare systems.
Osteofy was founded to change this. By extracting bone health insights from medical imaging that clinics already have on hand, we make opportunistic screening a reality — without additional scans, additional cost, or additional burden on patients.
2,540,000+
Scans Processed
<30s
Avg Processing Time
Upcoming
Healthcare Centres
99.7%
System Uptime
Osteofy was founded by a multidisciplinary team of clinicians, biomedical engineers, and AI researchers united by a shared frustration: osteoporosis — one of the most common and debilitating conditions in aging populations — was going undetected in millions of people every year.
The team recognised that while DXA scanners remain the gold standard, their cost and limited availability create a fundamental access problem. Chest X-rays, on the other hand, are among the most commonly performed radiological examinations worldwide. Every day, vast numbers of these images pass through picture archiving and communication systems (PACS) — rich with bone health information that goes unanalysed.
The founding insight was straightforward: what if we could unlock that latent diagnostic signal? Over several years of research, validation, and clinical collaboration, the team developed a multi-region deep learning pipeline capable of extracting clinically meaningful bone mineral density estimates from standard chest radiographs — validated rigorously against DXA reference measurements.
Today, Osteofy is working with healthcare providers and hospital networks to deploy this capability at scale — bringing automated BMD screening to the point of care, integrated directly into clinical workflows.
Evidence-First
Every capability we build is grounded in peer-reviewed methodology and validated against established clinical reference standards. We do not speculate — we measure.
Patient Centred
Better screening should reach the people who need it most. We design for accessibility, equity, and outcomes — not just the best-resourced healthcare settings.
Clinically Rigorous
Our results are clinical decision-support tools. We set high bars for accuracy, communicate uncertainty clearly, and always defer to qualified clinicians for final interpretation.
Curious about the science?
Explore the full technical methodology behind our chest X-ray BMD analysis pipeline — from image preprocessing and deep learning segmentation to DXA validation results and clinical considerations.
HIPAA Compliant
All data transmission uses TLS 1.3 encryption. Patient data is encrypted at rest with AES-256. We sign Business Associate Agreements with enterprise customers.
SOC 2 Type II
Our infrastructure undergoes regular third-party security audits. We maintain SOC 2 Type II compliance for data security, availability, and confidentiality.
GDPR Ready
Data processing meets GDPR requirements for EU-based customers. Data residency options available for organisations with geographic data requirements.
Access Controls
Role-based access control (RBAC) for multi-user environments. Audit logging tracks all data access and modifications for compliance reporting.